These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22652027)

  • 1. Malignant pleural effusion: tumor-host interactions unleashed.
    Stathopoulos GT; Kalomenidis I
    Am J Respir Crit Care Med; 2012 Sep; 186(6):487-92. PubMed ID: 22652027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
    Psallidas I; Stathopoulos GT; Maniatis NA; Magkouta S; Moschos C; Karabela SP; Kollintza A; Simoes DC; Kardara M; Vassiliou S; Papiris SA; Roussos C; Kalomenidis I
    Oncogene; 2013 Jan; 32(4):528-35. PubMed ID: 22370646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of malignant pleural effusion.
    Stathopoulos GT; Kalomenidis I
    Curr Opin Pulm Med; 2009 Jul; 15(4):343-52. PubMed ID: 19387350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid is effective against experimental malignant pleural effusion.
    Stathopoulos GT; Moschos C; Loutrari H; Kollintza A; Psallidas I; Karabela S; Magkouta S; Zhou Z; Papiris SA; Roussos C; Kalomenidis I
    Am J Respir Crit Care Med; 2008 Jul; 178(1):50-9. PubMed ID: 18388351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching off malignant pleural effusion formation-fantasy or future?
    Spella M; Giannou AD; Stathopoulos GT
    J Thorac Dis; 2015 Jun; 7(6):1009-20. PubMed ID: 26150914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion.
    Fang F; Chen P; Wu X; Yang L; Yang X; Xi ZX; Zhou BW; Zhou XK; Qian ZY; Xiao B; Wei YQ
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1149-57. PubMed ID: 19219619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
    Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
    Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
    Marazioti A; Kairi CA; Spella M; Giannou AD; Magkouta S; Giopanou I; Papaleonidopoulos V; Kalomenidis I; Snyder LA; Kardamakis D; Stathopoulos GT
    PLoS One; 2013; 8(8):e71207. PubMed ID: 23967166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Endostar combined with angiopoietin-2 inhibitor on malignant pleural effusion in mice.
    Fang SC; Zhang HT; Hu HD; Wang CY; Zhang YM
    Med Oncol; 2015 Jan; 32(1):410. PubMed ID: 25479942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
    Magkouta S; Pappas A; Moschos C; Vazakidou ME; Psarra K; Kalomenidis I
    Oncotarget; 2016 Apr; 7(15):20249-59. PubMed ID: 26959120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
    Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
    J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
    Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutical effects of pleural injecting recombinant human endostain to 
malignant pleural effusion nude mice model].
    Zhou M; Li M; Yang H; Hu C
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine is effective for the malignant pleural effusion associated with lung cancer in mice.
    Cui R; Yoshioka M; Takahashi F; Ishida H; Iwakami S; Takahashi K
    Anticancer Res; 2008; 28(3A):1633-9. PubMed ID: 18630520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of malignant-associated pleural effusion on endothelial viability, motility and angiogenesis in lung cancer.
    Changchien CY; Chen Y; Chang HH; Chang SY; Tsai WC; Tsai HC; Wang CY; Lee HS; Tsai CL
    Cancer Sci; 2020 Oct; 111(10):3747-3758. PubMed ID: 32706142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
    Schwalk AJ; Ost DE; Saltijeral SN; De La Garza H; Casal RF; Jimenez CA; Eapen GA; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Elamin Y; Zhang J; Roth JA; Swisher S; Heymach JV; Grosu HB
    Chest; 2021 Mar; 159(3):1256-1264. PubMed ID: 33217413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.